Rovulez-F Tablet

Description

Rosuvastatin 10 mg & Fenofibrate 160 mg tablets for cholesterol and triglyceride management. WHO-GMP certified cardiac tablets available for pharma franchise & PCD business.

Product Description:

Rosuvastatin 10 mg + Fenofibrate 160 mg Tablet is a powerful combination therapy used for the management of dyslipidemia (abnormal lipid levels). It helps reduce bad cholesterol (LDL), triglycerides, and improves good cholesterol (HDL) levels, thereby lowering the risk of cardiovascular diseases.

Rosuvastatin – Reduces cholesterol synthesis in the liver
Fenofibrate – Lowers triglycerides and improves lipid metabolism

Manufactured in WHO-GMP certified facilities, this formulation ensures superior quality, safety, and consistent therapeutic effectiveness. With rising cases of lifestyle disorders, this is a high-demand chronic therapy product, ideal for expanding pharma franchise cardiac portfolios.

Key Benefits:

✔ Reduces LDL cholesterol and triglycerides
✔ Increases HDL (good cholesterol)
✔ Helps prevent heart attack and stroke
✔ Improves overall lipid profile
✔ Dual mechanism for better cardiovascular protection
✔ WHO-GMP certified quality manufacturing
✔ High demand cardiac product for pharma franchise

Composition:

Rosuvastatin 10 mg
Fenofibrate 160 mg

Indications / Uses:

Dyslipidemia
High cholesterol
Hypertriglyceridemia
Cardiovascular risk reduction
Mixed lipid disorders

Dosage Form:

Tablets
(Dosage should be taken as directed by physician)

Packaging:

Blister / Alu-Alu packaging
Premium chronic therapy packaging available

Pharma Franchise Opportunity:

We offer Rosuvastatin + Fenofibrate Tablet Pharma Franchise with:

✅ Monopoly franchise rights
✅ WHO-GMP certified manufacturing
✅ High demand cardiac care product
✅ Strong promotional and marketing support
✅ Competitive pricing with attractive margins

This product is a valuable addition to cardiac and lipid management pharma franchise portfolios, ensuring consistent prescription demand and long-term business growth.